1997
DOI: 10.1038/sj.onc.1201500
|View full text |Cite
|
Sign up to set email alerts
|

A novel protein with strong homology to the tumor suppressor p53

Abstract: The p53 tumor suppressor orchestrates a number of important genes involved in cell-cycle control and apoptosis. Mice de®cient for p53 show a high incidence of cancer but are developmentally normal suggesting that compensatory mechanisms exist in embryogenesis and dierentiation. The new KET protein is the ®rst mammalian protein with strong homology to p53 in all evolutionary conserved regions. This conservation makes a functional redundancy of the two proteins in cell-cycle control possible. KET is expressed du… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
191
0
2

Year Published

1998
1998
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 257 publications
(199 citation statements)
references
References 14 publications
3
191
0
2
Order By: Relevance
“…They di er considerably at the C-terminus, with both p73 (Kaghad et al, 1997) and p63 (Schmale and Bamberger, 1997) having long extensions whereas p63 has in addition a 40 amino acid N-terminal extension. The ®nding of p53 homologs may explain the fact that p53-null mice develop mostly normally.…”
Section: The Emerging P53 Familymentioning
confidence: 99%
“…They di er considerably at the C-terminus, with both p73 (Kaghad et al, 1997) and p63 (Schmale and Bamberger, 1997) having long extensions whereas p63 has in addition a 40 amino acid N-terminal extension. The ®nding of p53 homologs may explain the fact that p53-null mice develop mostly normally.…”
Section: The Emerging P53 Familymentioning
confidence: 99%
“…Generation of alternative pathways can also be mediated by cellular homologues. However, in the case of p53, although several such candidates were suggested (Jost et al, 1997;Kaghad et al, 1997;Schmale and Bamberger, 1997), none of them seemed to serve as an ideal p53 analogue. Interestingly, in these newly discovered`homologues' of the p53 protein, alternative splicing of mRNA is frequently observed.…”
Section: Discussionmentioning
confidence: 99%
“…Mutations in p53 occur in nearly half of all human tumors (Olivier et al, 2002). p63 and p73 share structural homology with p53, particularly in their DNA-binding domains, with >60% amino acid identity (Kaghad et al, 1997;Schmale and Bamberger, 1997;Osada et al, 1998;Trink et al, 1998;Yang et al, 1998;Zeng et al, 2001). All three proteins take part in the regulation of cell cycle progression and apoptosis, and are expressed as several different isoforms because of alternative promoter usage and splicing.…”
Section: Introductionmentioning
confidence: 99%